Cerebrolysin vs Pinealon for sleep
Short answer: For sleep, users rate them about the same: 100% report improvement with Cerebrolysin (5 reports) and 100% with Pinealon (5 reports).
Cerebrolysin has 30 meta-analyses and 60 randomized trials on PubMed; Pinealon has 0 and 0.
Based on 228 reports about Cerebrolysin and 44 about Pinealon. Not medical advice.
| Cerebrolysin Peptide | Pinealon Peptide | |
|---|---|---|
| Users say it helped | 73%helped59 reports · medium confidence | 91%helped10 reports · few reports |
| Verdict | Mostly positive | Mostly positive |
| Research | AResearch: Strong | DResearch: None |
| Meta-analyses / RCTs | 30 / 60 | 0 / 0 |
| Mainly used for | ||
| Memory % reporting improvement | 97% (31) | 100% (4) |
| Focus % reporting improvement | 92% (24) | 100% (3) |
| Mood % reporting improvement | 90% (20) | — |
| Sleep % reporting improvement | 100% (5) | 100% (5) |
| Energy % reporting improvement | 89% (9) | — |
| Common side effects | fatigue, headache, tingling, less sleep | None reported |
| Typical dose reported | Not listed | Not listed |
Ginkgo biloba extracts have shown the greatest cognitive and functional benefits, though their clinical significance remains uncertain, and certainty of evidence is overall low. Future trials should focus on a single VCI subtype, prioritize interventions with a strong mechanistic rationale, standardize diagnostic criteria, ensure adequate power for chosen outcomes, test against placebo, and implement FAIR data sharing to accelerate therapeutic discovery.
Alzheimers Dement, 2025 ↗“Cerebrolysin is by far the best nootropic I have ever used...my memory, recall ability, sensitivity to music, observance over my emotions, thinking faculties have all improved to a noticeable amount.”
“No peptide has done as much for me as Pinealon. I feel like it shook a decade's worth of cobwebs loose from my brain.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate